《大行報告》高盛下調贛鋒鋰業(01772.HK)目標價至86元 評級「買入」
高盛發表報告指,贛鋒鋰業(01772.HK)去年淨利潤達205億元人民幣,按年升近3倍。該行指,去年業績表現勝於該行及市場預期,主要是電池業務表現較預期強勁,公司派發每股現金股息為1元,意味派息比率為10%,高於去年的8%。
該行將公司在2023年至25年經常性盈利預測下調8%至18%,考慮到最近的項目更新,由於滯後的合同價格調整,上半年按市值計價的碳酸鋰價格,部分被電池業務更好的利潤率和更高的全年氫氧化鋰利差假設所抵銷,目標價相應由115元下調至86元,維持評級為「買入」。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.